Prix De L'Action
664.60
Variation Quotidienne
-12.60 -1.86%
Mensuellement
8.42%
Annuel
20.27%
Q2 Prévisions
651.81




Créances Commerciales Changement Date
AstraZeneca USD 19.05B 1.49B 2025-12
Galapagos EUR 199.75M 122.08M 2025-12
Genmab DKK 1.17B 119M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
GRIFOLS EUR 852M 244.52M 2025-12
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
UCB EUR 1.97B 54M 2025-12